16770 results for "sec+and+unspecified+malignant+neoplasm"

in 23.74 milliseconds.

• Spatiotemporal single cell transcriptomic analysis of human gut macrophages reveals multiple functional and niche-specific subsets

  Study EGAS00001005377

• The cell free DNA methylome of primary and metastatic prostate tumors

  Study EGAS00001005522

• Case Report: early contribution of germline and nevi genetic alterations to a rapidly-progressing Cutaneous Melanoma Patient

  Study EGAS00001006459

• Patient WGS for #198

  Whole genome sequencing of patient tumour and blood

  Dataset EGAD50000000217

• Pleural_mesothelioma

  EPIC methylation data of pleural mesothelioma samples and healthy pleura samples

  Dataset EGAD00010002657

• Healthy_pleura

  EPIC methylation data of pleural mesothelioma samples and healthy pleura samples

  Dataset EGAD00010002656

• USA-Immuno

  USA Multiple Sclerosis cases and controls

  Dataset EGAD00010002043

• yemcha-U-2

  Yemen and Chad Genotyping

  Dataset EGAD00010001867

• REL-2017-07-2013

  HipSci - Bleeding and Platelet Disorders - Genotyping Array - July 2017

  Dataset EGAD00010001360

• MacTel_cohort_Omni5_genotypes

  MacTel Projet consortium case and control genotypes from Ilumina Omni5 chip

  Dataset EGAD00010001204

• Clinical and genetic analysis of a rare syndrome associated with neoteny

  Dataset EGAD00001003593

• Whole-exome and low-coverage whole genome sequencing data

  Dataset EGAD00001001391

• Whole-Genome Bisulfite Sequencing of a paired initial and recurrent glioma

  Dataset EGAD00001001616

• BiSeqS

  Runs that contain data for the sensitivity and specificity experiments for BiSeqS.

  Dataset EGAD00001003323

• DONSON exome data

  Exome data from patients and parents with DONSON mutations

  Dataset EGAD00001003160

• PDAC

  ctDNA and protein markers for earlier detection of pancreatic cancers

  Dataset EGAD00001004399

• Clinical data

  Clinical data including the treatment arm, HER2 status Pre- and Post-NAT.

  Dataset EGAD00001009414

• Data access committee for white blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer

  Dac EGAC00001001435

• Data Access Commitee - Monocyte and macrophage lipid accumulation results in downregulated type-I interferon responses - FH monocytes RNA sequencing data

  Dac EGAC00001002495

• Time series analysis of neoadjuvant chemotherapy and bevacizumab treated breast carcinomas reveals a systemic shift in genomic aberrations

  Study EGAS00001003287

• IMPRESS: Improved Methylation Profiling using Restriction Enzymes and smMIP Sequencing, Combined with New Biomarker Panel, Creating Multi-Cancer Detection Assay

  Study EGAS00001007559

• DAC for DLBCL dataset

  Data Access Committee for cfDNA sequencing dataset from 290 samples from patients with DLBCL and HGBL.

  Dac EGAC50000000257

• Kerl Pediatric Oncology Münster

  Kerl lab at the Department of Pediatric Hematology and Oncology, University Hospital Münster, Münster, Germany

  Dac EGAC50000000765

• DNA polymerase and mismatch repair deficient cancers exert distinct genome-wide microsatellite signatures 2

  Study EGAS00001004816

• Clonal dynamics of normal hepatocyte expansions in homeostatic human livers and their association with the biliary epithelium

  Study EGAS00001005539

• The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.

  Study EGAS00001005827

• The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.

  Study EGAS00001006088

• The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.

  Study EGAS00001006122

• Single cell characterization of arrested B-lymphoid differentiation and leukemic cell states in ETV6-RUNX1-positive pediatric leukemia

  Study EGAS00001004374

• Whole Exome Sequencing of Schizophrenia cases and controls performed at the Broad Institute on a cohort from Bristol, UK

  Study EGAS00001006274

• Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

  Study EGAS00001004615

• Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models

  Study EGAS00001006134

• Complex patterns of genomic heterogeneity identified in 42 tumor samples and ctDNA of a pulmonary atypical carcinoid patient

  Study EGAS00001006530

• Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer

  Study EGAS00001007430

• PDX WGS for #264

  WGS of tumour PDX and matched patient blood

  Dataset EGAD50000000033

• Panamanian genotype data

  84 Indigenous and admixed individuals from Panama genotyped with Axiom Human Origins (Affymetrix)

  Dataset EGAD00010002473

• HomoCulturGen

  86 samples from four human populations: two from Central Asia and two from Southeast Asia

  Dataset EGAD00010002663

• Germany-Immuno

  Germany Multiple Sclerosis cases and normal controls

  Dataset EGAD00010002044

• Belgium-Immuno

  Belgium Multiple Sclerosis cases and normal controls

  Dataset EGAD00010002045

• France-Immuno

  France Multiple Sclerosis cases and normal controls

  Dataset EGAD00010002046

• AUSNZ-Immuno

  Australia and New Zealand Multiple Sclerosis case

  Dataset EGAD00010002047

• OGVP_HC24_Controls

  Healthy adult volunteers and newborns recruited in various countries across Oceania.

  Dataset EGAD00010000953

• BCC exomes and transcriptomes

  Dataset EGAD00001001857

• Summary data from case control analysis

  Summary data from GWAS analysis on 856 cases and 2836 control

  Dataset EGAD00000000115

• EGAD00000000059

  Aggregate results from 43 Carbamazepine-induced hypersensitivity syndrome patients and 1296 1958 British Birth Cohort control samples

  Dataset EGAD00000000059

• EGAD00000000058

  Aggregate results from 22 Carbamazepine-induced hypersensitivity syndrome patients and 2691 UK National Blood Service (NBS) control samples

  Dataset EGAD00000000058

• AML WGS bam

  WGS bam files for paired diagnostic and remission samples

  Dataset EGAD00001015515

• An approach for evaluating the effects of dietary fiber polysaccharides on the human gut microbiome and plasma proteome

  Study EGAS00001005330

• WGS data for NRF2 study

  WGS data for cell lines and clinical samples

  Dataset EGAD00001002244

• Resuscitation Outcomes Consortium Pragmatic Trial of Airway Management in out-of-Hospital Cardiac Arrest (ROC PART-BioLINCC)

  Data Access NOTE: Please refer to the “Authorized Access” section below for information about how access to the data from this accession differs from many other dbGaP accessions.Objectives: To determine the effect of an initial airway management strategy using laryngeal tube (LT) insertion, compared with endotracheal intubation (ETI), on survival among adults with out-of-hospital cardiac arrest (OHCA).Background: Out-of-hospital cardiopulmonary arrest (OHCA) affects more than 350,000 adults in the United States each year, with only a low percentage of patients surviving to hospital discharge. Emergency medical services (EMS) paramedics commonly perform ETI or insertion of supraglottic airways (SGAs), such as the LT, on patients with OHCA to facilitate oxygenation and protect the lungs from aspiration of vomitus. Because SGA insertion is rapid, simple, and requires less training compared to ETI, many EMS agencies have incorporated this as the primary method of ventilation during OHCA resuscitation. However, the optimal method for OHCA advanced airway management is unknown.Participants: A total of 3004 patients were included; 1505 assigned to initial LT and 1499 assigned to initial ETI.Design: PART was a multicenter cluster-crossover randomized trial. The trial included 27 EMS agencies associated with US sites of the Resuscitation Outcomes Consortium (ROC). The EMS agencies were grouped into 13 randomization clusters. Each cluster selected a crossover interval of 3 or 5 months. Within each cluster, treatment assignments for consecutive intervals were computer-randomized in blocks of 2 to ensure balanced exposure to both airway groups. Crossovers between study groups could occur more than once. Treatment assignments were initial LT insertion or initial ETI. Neuromuscular blocking agents or video laryngoscopy was permitted for initial intubation efforts. The trial did not limit the number of initial LT insertion or ETI attempts. If the initial insertion efforts were unsuccessful, EMS personnel performed rescue airway management using any available airway technique. EMS personnel followed local protocols for confirmation of airway placement and management of OHCA, including field termination of resuscitation efforts. Patients receiving bag-valve mask (BVM) ventilation only were retained in their assigned treatment group per intention-to-treat principles. The trial did not prescribe clinical care at the receiving hospitals, including use of EMS airway, targeted temperature management, percutaneous coronary intervention, or the timing of withdrawal of life-sustaining therapy.The primary outcome was 72-hour survival. Secondary outcomes included return of spontaneous circulation, survival to hospital discharge, and favorable neurological status at hospital discharge (Modified Rankin Scale score ≤3). Conclusions: Among adults with OHCA, a strategy of initial LT insertion was associated with significantly greater 72-hour survival compared with a strategy of initial ETI. These findings suggest that LT insertion may be considered as an initial airway management strategy in patients with OHCA, but limitations of the pragmatic design, practice setting, and ETI performance characteristics suggest that further research is warranted.

  Study phs003902